The World Market for Veterinary Diagnostics, 8th Edition

If you’re looking to navigate the complex and fast-growing veterinary diagnostics landscape, The World Market for Veterinary Diagnostics, 8th Edition is your essential guide. Packed with actionable intelligence, industry trends, and market projections, this report equips you with the knowledge to make informed business decisions and seize emerging opportunities in this high-growth sector.

The veterinary diagnostics industry is undergoing a period of rapid expansion, driven by advancements in in vitro diagnostic (IVD) technology, increasing pet ownership, and the growing need for disease control in livestock. Kalorama Information’s latest market research report, The World Market for Veterinary Diagnostics, 8th Edition, provides a deep dive into this evolving sector, offering strategic insights, market sizing, and forecasts that highlight key growth opportunities for industry stakeholders from 2024-2029.

A Growing Market with Expanding Applications

Veterinary diagnostics play a crucial role in ensuring animal health, whether through routine screenings, disease monitoring, or zoonotic disease surveillance. The market has demonstrated consistent growth, even through economic fluctuations, reflecting the rising consumer spending on companion animals and the critical role of diagnostic testing in food animal disease management. For IVD companies, this presents a lucrative opportunity to adapt human diagnostics for veterinary applications, leveraging cutting-edge technology to meet the increasing demand for rapid, accurate, and reliable animal health testing.

Market Segmentation & Key Drivers

The global veterinary diagnostics market is segmented into two primary areas:

  • Companion Animal Diagnostics – Fueled by increasing pet ownership and higher standards of veterinary care, this segment benefits from advancements in molecular testing, immunoassays, and digital imaging.
  • Food Animal Diagnostics – Critical for livestock disease prevention and food safety, this segment is led by infectious disease testing and surveillance programs aimed at ensuring agricultural productivity and preventing zoonotic disease outbreaks.
  • Other key market drivers include:
  • Advancements in Diagnostic Technology – The crossover of IVD platforms from human healthcare to veterinary medicine is revolutionizing disease detection, enabling more precise and efficient testing solutions.
  • Rising Demand for Disease-Specific Testing – From feline leukemia and bluetongue disease to zoonotic threats like brucellosis and avian influenza, specialized diagnostic tests are in high demand across global veterinary markets.
  • Regional Market Growth – The United States, Europe, and Asia Pacific lead the veterinary diagnostics industry, with increasing investment in animal health research and regulatory initiatives supporting market expansion.
Data-Driven Scope and Methodology

This report is built on a combination of primary and secondary research, including expert interviews, company financials, government reports, and veterinary publications. It provides comprehensive market analysis, revenue forecasts, and strategic insights tailored for diagnostics manufacturers, veterinary professionals, and investors looking to capitalize on the rising demand for animal health solutions.


  • Market Analysis: Cardiac Biomarker Testing
    • Overview of Cardiac Biomarkers
  • Market Outlook
    • Table Cardiac Marker Testing Market by End User, 2024-2029 ($ million) (Lab-based, POC-based)
    • Table Cardiac Marker Diagnostic Sales by End User, 2024-2029 ($ million) (Lab-based, POC-based)
    • Table Cardiac Marker Testing Market by End User and Total Value Over Time, 2019-2029 ($ million) (Lab-based, PoC-based)
    • Table Cardiac Marker Testing Market, by Marker, 2024 (% Share) (Troponin, BNP, CK-MB, Myoglobin, Other)
    • Regional Market
      • Table Cardiac Marker Test Sales Distribution by Global Region, 2024 (%) (Asia Pacific, Europe, North America, RoW)
    • Company Briefs
      • Abbott Diagnostics
      • Beckman Coulter
      • Siemens
    • Vendor Market Share
      • Table Market Share of Leading Vendors in the Cardiac Marker Segment, by Company, 2024 (%) (Abbott, Danaher, QuidelOrtho, Roche, Siemens, Others)
  • Executive News Briefing
    • Briefs
      • Senseera Closes $7.1 Million in Funding Round
      • Geneoscopy Closes Series C Funding
      • Oxford Cancer Analytics Raises $11 Million in Series A Funding
      • MiRXES Nabs $40 Million in Financing
      • Tethis Nabs €15 Million Funding
  • Financial Highlights: Becton Dickinson, Natera
    • Becton Dickinson Reports 4% Revenue Growth in Fiscal 2024
      • Table Becton Dickinson Financial Review, by Business Segment, FY 2022-FY 2024 ($ million) (BD Medical, BD Life Sciences, BD Interventional)
      • Table Becton Dickinson Business Division Performance, by Business Segment, FY 2022-FY 2024 ($ million) (BD Medical, BD Life Sciences, BD Interventional)
      • Table BD Life Sciences Division, Segment Mix, FY 2020 vs. FY 2024 (%) (Integrated Diagnostic Solutions, Biosciences)
      • Table Becton Dickinson U.S./International Revenue Distribution, FY 2022-FY 2024 ($ million)
      • Table Becton Dickinson Revenue Distribution, by Region, FY 2024 (%) (EMEA, Greater Asia, United States, Other)
    • Natera Continues Overall Growth Trend with Preliminary 2024 Results, Expecting a 56% Increase over 2023
      • Table Natera Financial Overview by Quarter, Q1 2023-Q4 2024* ($ million)
  • Diagnostic Market Mergers, Acquisitions, and Partnership Deals
    • Partnerships and Collaborations
    • Mergers and Acquisitions
      • Table Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals, Dec. 2023-Jan. 2025
  • Industry Watch
    • Industry Watch COVID-19/Flu Update
  • Region Watch
    • Mexico
      • Table Mexico GDP, GDP (PPP), and Health Spending, 1990-2020, estimated 2025 ($ billion)
      • Table Mexico IVD Market Sales Trends, by Broad IVD Segment, 2016-2024 ($ million) (Clinical Chemistry, Hematology, and Coagulation; Histology; Immunoassays; Microbiology; POC; Others)
  • Broad-based Company Announcements
    • Announcements
      • Roche Secures CE Marking for Mass Spec System
      • QIAGEN Receives FDA Clearance for Five-Target Syndromic Panel
      • Revvity Secures FDA Clearance for Free Testosterone Test
      • Spear Bio Secures FDA Breakthrough Device Designation
      • Roche Announces Clearance of First ISH Test B-cell Lymphoma
      • Roche Receives Additional FDA Clearance

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings